View in EDS

Drug-Resistant Epilepsy in Tuberous Sclerosis Complex Is Associated With TSC2 Genotype: More Findings From the Preventing Epilepsy Using Vigatrin (PREVeNT) Trial.

Saved in:
Bibliographic Details
Title: Drug-Resistant Epilepsy in Tuberous Sclerosis Complex Is Associated With TSC2 Genotype: More Findings From the Preventing Epilepsy Using Vigatrin (PREVeNT) Trial.
Authors: Farach, Laura S.1 (AUTHOR) Laura.S.Farach@uth.tmc.edu, Richard, Melissa A.2 (AUTHOR), Wulsin, Aynara C.3 (AUTHOR), Bebin, Elizabeth M.4 (AUTHOR), Krueger, Darcy A.3 (AUTHOR), Sahin, Mustafa5,6 (AUTHOR), Porter, Brenda E.7 (AUTHOR), McPherson, Tarrant O.8 (AUTHOR), Peters, Jurriaan M.5,6 (AUTHOR), O'Kelley, Sarah9 (AUTHOR), Taub, Katherine S.10 (AUTHOR), Rajaraman, Rajsekar11 (AUTHOR), Randle, Stephanie C.12 (AUTHOR), McClintock, William M.13 (AUTHOR), Koenig, Mary Kay1 (AUTHOR), Frost, Michael D.14 (AUTHOR), Werner, Klaus15 (AUTHOR), Nolan, Danielle A.16 (AUTHOR), Wong, Michael17 (AUTHOR), Cutter, Gary18 (AUTHOR)
Source: Pediatric Neurology. Oct2024, Vol. 159, p62-71. 10p.
Database: Academic Search Ultimate
Description
ISSN:08878994
DOI:10.1016/j.pediatrneurol.2024.06.012